These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 26656101)
1. Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels. Ilatovskaya DV; Levchenko V; Lowing A; Shuyskiy LS; Palygin O; Staruschenko A Sci Rep; 2015 Dec; 5():17637. PubMed ID: 26656101 [TBL] [Abstract][Full Text] [Related]
2. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease. Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963 [No Abstract] [Full Text] [Related]
3. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445 [TBL] [Abstract][Full Text] [Related]
4. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Ilatovskaya DV; Staruschenko A Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930 [TBL] [Abstract][Full Text] [Related]
5. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714 [TBL] [Abstract][Full Text] [Related]
9. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression. Ma R; Liu L; Jiang W; Yu Y; Song H Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720 [TBL] [Abstract][Full Text] [Related]
10. The Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling. Ilatovskaya DV; Palygin O; Levchenko V; Endres BT; Staruschenko A Sci Rep; 2017 Mar; 7(1):299. PubMed ID: 28331185 [TBL] [Abstract][Full Text] [Related]
11. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy. Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318 [TBL] [Abstract][Full Text] [Related]
12. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469 [TBL] [Abstract][Full Text] [Related]
13. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats. Zhang X; Song Z; Guo Y; Zhou M Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induces calcium-mediated autophagy in podocytes through enhancing reactive oxygen species levels. Gao N; Wang H; Yin H; Yang Z Chem Biol Interact; 2017 Nov; 277():110-118. PubMed ID: 28916337 [TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes. Li Z; Xu J; Xu P; Liu S; Yang Z Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354 [TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079 [TBL] [Abstract][Full Text] [Related]
18. Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy. Bohovyk R; Khedr S; Levchenko V; Stefanenko M; Semenikhina M; Kravtsova O; Isaeva E; Geurts AM; Klemens CA; Palygin O; Staruschenko A Diabetes; 2023 Dec; 72(12):1795-1808. PubMed ID: 37722138 [TBL] [Abstract][Full Text] [Related]
19. Reorganization and Suppression of Store-Operated Calcium Entry in Podocytes of Type 2 Diabetic Rats. Gusev K; Shalygin A; Kolesnikov D; Shuyskiy L; Makeenok S; Glushankova L; Sivak K; Yakovlev K; Orshanskaya Y; Wang G; Bakhtyukov A; Derkach K; Shpakov A; Kaznacheyeva E Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108424 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease. Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]